OpenAI's IPO Timeline Keeps Shifting. Here Is What the Current State of Play Actually Looks Like.
OpenAI confidentially filed for an IPO on June 8, 2026, working with Goldman Sachs and Morgan Stanley as lead underwriters, with JPMorgan also involved. The filing set up a potential public debut between September and November 2026, targeting a raise of approximately $60 billion at a valuation approaching $1 trillion. Then SpaceX listed, fell 30% from its post-IPO high, and OpenAI's advisers concluded the market would not support a $1 trillion valuation in the near term.
CEO Sam Altman has called any valuation reduction a "nonstarter."
CFO Sarah Friar has separately flagged operational reasons to wait.
Neither position has changed publicly since the June delay reporting.
What OpenAI Actually Filed
The June 8 confidential S-1 filing is the structural fact that anchors the rest of this. A confidential filing gives OpenAI the option to go public on a shorter timeline without committing to a specific date. The SEC review process, S-1 amendments, and roadshow preparation would occupy Q3 2026, with an actual IPO window opening in Q4 if the company chooses to proceed, and that window is still open.
OpenAI's annualised revenue passed $20 billion at end-2025 and reached approximately $25 billion by February 2026, with enterprise accounting for more than 40% of revenue and on track to reach parity with consumer by year-end, growing four times faster than Alphabet and Meta did at comparable stages. A $1 trillion target requires roughly a 17% premium over OpenAI's last private mark of $852 billion, set in March 2026, and OpenAI's own advisers concluded that premium was not achievable at current market conditions. The question for Q4 is whether conditions improve enough for Altman to accept a valuation between $852 billion and $1 trillion, or whether he holds out for the round number into 2027.
What makes the decision harder is that OpenAI remains deeply unprofitable. Internal projections reportedly point to losses of around $14 billion in 2026 alone, with profitability not expected until roughly 2029 to 2030. An operating loss of nearly $21 billion was booked in 2025. A company burning at that rate at a $1 trillion valuation is a different investment proposition from a traditional growth equity listing, and the public market investors who will anchor the book are the ones who will decide whether the growth trajectory justifies the losses.
The SoftBank Problem
The most concrete forcing function on OpenAI's timeline is sitting on SoftBank's balance sheet. SoftBank took out a $40 billion unsecured bridge loan from JPMorgan, Goldman Sachs, and Japanese banks to fund its OpenAI investment, with repayment due March 25, 2027. SoftBank holds approximately 13% of OpenAI, making it the second-largest external shareholder behind Microsoft's 27%, with a fair value of $79.6 billion against a cumulative cost of $34.6 billion at year-end 2025.
The original assumption was that OpenAI would go public in 2026, allowing SoftBank to sell down enough of its stake to repay the loan. With the IPO delayed, SoftBank faces a collision between a market event and a debt deadline that OpenAI's management does not share. Altman has the luxury of waiting for his number. SoftBank needs to find $40 billion by March 2027, one way or another.
The delay announcement wiped $38 billion from SoftBank's market capitalisation in a single trading session, signalling how much of SoftBank's current valuation rests on the assumption that OpenAI's private marks translate to public market prices. A 2027 IPO at a valuation between $852 billion and $1 trillion would still be an extraordinary outcome for SoftBank. The problem is the gap between when SoftBank needs the exit and when OpenAI is willing to provide one.
The Anthropic Variable
Anthropic filed its confidential S-1 on June 1, a week before OpenAI, and is still tracking toward an October 2026 listing. Anthropic is racing to set the public market pricing benchmark for AI inference revenue before OpenAI does, and if it lists in October at a strong valuation, it establishes the comparable that OpenAI has to clear. OpenAI listing after Anthropic also means ceding first-mover positioning to its primary competitor, and a $900 billion listing before Anthropic's October debut is a different strategic calculation from a $900 billion listing after it.
That competitive pressure is one of the few forces that could pull OpenAI's timeline back toward 2026 even if Altman's $1 trillion condition is not met.
The Governance Detail Nobody Is Talking About
One structural question the S-1 will need to answer: Sam Altman holds zero equity in OpenAI. His equity line in the restructured cap table shows "TBD." Whether he receives a meaningful equity grant before the IPO is a governance question that institutional investors anchoring a trillion-dollar listing will want resolved before they commit capital. A CEO with no equity in a company he is publicly insisting should be worth $1 trillion is an unusual situation by any standards, and it creates alignment questions that the prospectus will need to address directly.
CFO Sarah Friar, who joined in 2024, cited $600 billion in future infrastructure spending commitments and the difficulty of meeting public-company reporting standards on a compressed timeline as separate reasons to wait. The infrastructure commitment figure is itself a window into OpenAI's financial position: a company committing to $600 billion in future spending while running $14 billion annual losses needs public market capital, not for growth but for operational sustainability.
For pre-IPO investors already holding positions, the timeline uncertainty changes the liquidity horizon but not the underlying company. Our piece on the risks of private market investing covers what holding period uncertainty means in practice.
NonPublic Pty Ltd (ABN 49 607 216 928) holds Australian Financial Services Licence #482668. Investments are available to wholesale and sophisticated investors as defined under the Corporations Act 2001. This content is general in nature and does not constitute financial product advice. It does not take into account your objectives, financial situation, or needs. Investing in private markets involves significant risk, including the potential loss of your entire investment. Past performance is not a reliable indicator of future results. You should obtain independent financial advice before making any investment decision.
